XpertDox lands $20M to scale AI medical coding
What's the deal? XpertDoxDealroom has a profile for this one. Try Dealroom → has raised a $20 million Series A led by Savant GrowthDealroom has a profile for this one. Try Dealroom →, with funding from its investment partner Kennet PartnersDealroom has a profile for this one. Try Dealroom →. The Arizona-based company automates medical coding, converting clinical documentation in a provider's electronic health record into coded data for billing.
What's the endgame? XpertDox will use the money to speed up customer onboarding, deepen specialty coverage, and grow its engineering and customer teams. It also plans to expand its business intelligence platform with new dashboards aimed at helping healthcare organizations improve financial performance and build value-based care programs.
By the numbers: XpertDox says it doubled revenue over the past 12 months, with 126% net revenue retention and 95% customer retention. The company reports that its XpertCoding platform codes more than 91% of claims without manual intervention, returns them in under 24 hours, and keeps coding-related denials below 2%. Those are company-reported figures.
Why now? Community health centers operate on thin margins and need coding that is fast and defensible, said co-founder and chief executive officer Sameer Ather. "XpertCoding delivers that by turning clinical documentation into reliable, consistent data," he said. The company serves seven Federally Qualified Health Centers across six states, with more going live soon.
Javier Rojas, co-founder and managing partner of Savant Growth, joins the XpertDox board as part of the deal. "XpertDox gives healthcare organizations a consistent, well-documented data layer from the EHR," he said. "That's the foundation for process improvement and, increasingly, for AI-driven workflows."
The signal: The round lands amid rising investor interest in automating healthcare billing. Recent deals include Arintra's $25 million round in August and a $20 million Series A for France's Parallel in March, while chart-review startup Charta Health disclosed a $55 million Series B a day before XpertDox's announcement. The funding reads as a growth bet in a crowded, increasingly well-funded market — not an isolated wager on a new category.
Read more: morningstar.com
Image credit: Generated with Gemini
